At present, olverembatinib has been approved in China for the treatment of adult patients with TKI-resistant chronic-phase chronic myeloid leukemia (CML-CP) or accelerated-phase CML (CML-AP) harboring ...

Announcing a new article publication for Zoonoses journal. Zoonotic transmission of severe acute respiratory coronavirus 2 (SARS-CoV-2) has been found to result in infections in more than 30 mammalian ...

This pathway approach revealed that 1) 13 proteins were conserved, whereas five lacked data sufficient to determine specific critical amino acids; 2) variation in protein-protein interfaces is ...

SOUTH SAN FRANCISCO, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean ...

Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

Dr Miriam Stoppard delves deep into a new study looking at the way the immune system responds to a fever, which could lead to ...

A relatively easy way to encourage your Black patients with MS to participate in clinical research is to introduce them to ...

I am proposing that all companies currently engaged in developing biosimilars join hands with their regulatory and scientific ...

At The Liver Meeting 2024, Arbutus Biopharma Corp. presented data from the phase IIa Im-prove study showing its RNAi drug, imdusiran, in combination with pegylated interferon alfa-2α and nucleos(t)ide ...

Arbutus Biopharma (ABUS) announced new data from its IM-PROVE I Phase 2a clinical trial showing that six doses of imdusiran, the ...